title: [The characteristics of 62 cases of CD20-positive multiple myeloma].
abstract: OBJECTIVE
  To explore the clinical and laboratory characteristics of mutiple myeloma patients with CD20 expression.
  
  
  METHODS
  Review the data of mutiple myeloma patients and analyze the clinical and laboratory characteristics of CD20 positive patients, compared with CD20 negative patients.
  
  
  RESULTS
  (1)Totally 465 cases of newly-diagnosed MM were collected with CD20 expression status detected by multi-color flow cytometry. Sixty two patients (13.3%) were CD20 positive and the others were negative. (2)No statistical differences were found between CD20 positive and negative groups about the sex ratio, age predominance, D-S staging, ISS staging, renal insufficiency rate, platelet count, LDH level and classifications by paraprotein(all P value>0.05). (3)Compared with those of CD20 negative patients, the hemoglobulin value(74.5 g/L vs 83.5 g/L, P=0.021), extramedullary involvement rate (3.5% vs 13.7%, P=0.029), CD56-positive rate(36.7% vs 68.8%,P=0.000), t(4;14)translocation rate(2.4% vs 24.0%, P=0.001) in CD20 positive patients were lower statistically. (4)Compared with those of CD20 negative patients, the percentage of plasma cells (0.400 vs 0.295, P=0.045) by marrow smear differential counting, the percentage of myeloma cells(20.0% vs 6.8%, P=0.000) by multi-color flow cytometry analysis, CD45-positive rate(12.1% vs 4.5%, P=0.018), CD79a-positive rate(9.8% vs 1.5%, P=0.013) and t(11;14) translocation rate(60.5% vs 14.4%, P=0.000)in CD20 positive patients were higher statistically. (5)There was no statistical differences about the overall response rate (ORR), complete response rate (CRR), TTP(time to progression), PFS(progression free survival) and overall survival (OS) between CD20 positive and negative groups.
  
  
  CONCLUSIONS
  CD20 positive rate is 13.3% in multiple myeloma pateints according to our data. CD20 poaitive myeloma were prone to residing in bone marrow and affecting erythropoiesis. Atypical immunophenotypes were more common, and the incidence of t(11;14) were increased markedly while that of t(4;14)were rare for CD20 positive multiple myeloma.
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Zengjun
authors: Z
authors: Li
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Yan
authors: Y
authors: Xu
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Gang
authors: G
authors: An
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Huijun
authors: H
authors: Wang
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Shuhui
authors: S
authors: Deng
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Yaozhong
authors: Y
authors: Zhao
authors: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
authors: Lugui
authors: L
authors: Qiu
mesh_terms: D018951:Antigens, CD20; D001853:Bone Marrow; D018450:Disease Progression; D018572:Disease-Free Survival; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D017493:Leukocyte Common Antigens; D009101:Multiple Myeloma; D009194:Myeloma Proteins; D010950:Plasma Cells; D012074:Remission Induction; D014178:Translocation, Genetic
chemical_list: D018951:Antigens, CD20; D009194:Myeloma Proteins; C085016:multiple myeloma M-proteins; D017493:Leukocyte Common Antigens; C516769:PTPRC protein, human
references: Pathology. 2012 Oct;44(6):552-6
references: 22935987
references: Am J Clin Pathol. 2010 Feb;133(2):265-70
references: 20093236
references: Haematologica. 2008 Mar;93(3):431-8
references: 18268286
references: Blood. 2007 Apr 15;109(8):3489-95
references: 17209057
references: Am J Clin Pathol. 2007 Feb;127(2):176-81
references: 17210522
references: Blood. 2003 Aug 1;102(3):1070-1
references: 12702507
references: Br J Haematol. 2010 Apr;149(1):156-9
references: 19995388
references: Leukemia. 2007 Apr;21(4):835-6
references: 17268523
references: Am J Clin Pathol. 2004 Apr;121(4):482-8
references: 15080299